Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury | MicrobiomeTrials← Back to trialsNCT07795736
Charactertizing Growth Hormone Deficiency in Traumatic Brain Injury
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-06-01Est. Completion: 2028-03-01
Enrollment target: 200 participants Locations- Foothills Medical Center, Main Floor Special Services, Calgary, Alberta, Canada
- University of Calgary, Calgary, Alberta, Canada
Other microbiome trials you might be interested in
Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone)…
Washington D.C., United States
Growth Hormone Deficiency (GHD)
The OraGrowtH Phase 3 Trial is a multi-national trial. The goals of the trial are to study LUM-201 as a treatment for Pe…
Birmingham, United StatesEst. completion Dec 2027
Completed
This randomized, double-blind, placebo-controlled, parallel-group study evaluated the effects of six-month oral suppleme…
Wroclaw, PolandCompleted Jun 25, 2026